Nearly a year ago we concluded that AI Drug Discovery Stocks Continue to Disappoint. The best examples are two names we cover closely that seemingly pivoted from “exciting AI-enabled drug discovery platforms” to “risky in-house drug developers.” Since then, the two have run equally in opposite directions with one up +36% and one down 36% […]
Source link
AlphaStreet Newsdesk powered by AlphaStreet Intelligence JOUT|EPS $1.42 vs $0.68 est (+108.8%)|Rev $189.7M vs $186.2M est (+1.9%)|Net Income $14.9M Stock...
This week, we’ve explored two of the biggest questions surrounding artificial intelligence. First, just how close are we to artificial...
Doximity at the New York Stock Exchange for its initial public offering on June 24, 2021.Source: NYSEShares of medical platform...
It didn’t have to be Spokane. A fast-moving wildfire could sweep into the suburbs of any one of hundreds of...
AlphaStreet Newsdesk powered by AlphaStreet Intelligence SMA|ADJ FFO/Share $0.49 vs $0.11 est (+345.5%)|Rev $79.3M|Net Income $12.1M FY26 FFO/Share guidance –...
United Wholesale Mortgage at the NYSE, January 22, 2021Source: The New York Stock ExchangeShares in UWM Holdings, parent of United...
Get the latest news and follow the coverage of Business & Financial News, Stock Market Updates, Analysis, and more from the trusted sources.
-1024x682.jpg "Food Inflation, Jimmy Carter’s Sweater, and Burritos")
